Cargando…
PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival
BACKGROUND: Hepatocellular carcinoma (HCC) patients undergo liver-directed therapy (LDT) to control tumor burden while awaiting liver transplantation with response impacting waitlist survival. In this study, we investigate the link between absolute lymphocyte count (ALC) and PD-1 expression with res...
Autores principales: | Núñez, Kelley G., Sandow, Tyler, Fort, Daniel, Hibino, Mina, Wright, Paige, Cohen, Ari J., Thevenot, Paul T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122885/ https://www.ncbi.nlm.nih.gov/pubmed/34689234 http://dx.doi.org/10.1007/s00262-021-03087-z |
Ejemplares similares
-
Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates
por: Núñez, Kelley G., et al.
Publicado: (2022) -
Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma
por: Núñez, Kelley G., et al.
Publicado: (2021) -
Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed Therapy
por: Núñez, Kelley G., et al.
Publicado: (2022) -
Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation
por: Núñez, Kelley, et al.
Publicado: (2020) -
Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function
por: Núñez, Kelley, et al.
Publicado: (2018)